Q3 2019 Earnings Call
Good morning, and welcome to the third quarter 2019 earnings release Conference call for FMC Corporation.
All lines will be placed on listen only mode throughout the conference. After the speakers presentation. There will be a question and answer period, well now turn the conference are Mr., Michael really director Investor Relations for FMC Corporation Mr. Wilson, you may be yet.
Thank you and good morning, everyone.
Welcome to FMC Corporation third quarter earnings call.
Joining me today, our Pierre Brondeau, Chief Executive Officer, and Chairman, Mark Douglass, President and Chief operating Officer, and I understand for executive Vice President and Chief Financial Officer.
Here, where you see third quarter performance to provide the outlook for the remainder of 2019.
Arqule taken in depth look at our Latin America business, followed by Andrew Who'll provide an overview of select financial results.
He will then address your questions.
Slide presentation that accompanies our results along with our earnings release in our 2019 outlook statement are available on our website and the prepared remarks from today's discussion will be made available after the call.
Finally, let me remind you that today's presentation and discussion will include forward looking statements that are subject to various risks and uncertainties concerning specific factors, including but not limited to those factors identified in our press release and in our filings with the Securities and Exchange Commission.
Information presented represents our best judgment based on today's understanding.
Actual results May vary based on these risks and uncertainties.
Today's discussion and supporting materials will include references to adjusted EPS adjusted EBITDA adjusted cash flow operations and free cash flow all of which are non-GAAP financial measures. Please note that earnings show me, an adjusted earnings and EBITDA actually I mean, adjusted EBITDA for all income statement references.
A reconciliation definition or these terms as well with other non-GAAP financial terms to which we may refer during today's call conference call.
Provided on our website with that I'll now turn the call repair.
Thank you my cool and good morning, everyone.
And she continued to deliver strong financial performance and just sort of quarter and then you get a difficult market conditions.
In North America in Europe .
This.
He is called <unk> prior quarters due to a unique blend on balanced geographic exposure.
Strong sales in specialty crops and the signal EGAS vintage portfolio.
A good example, although all these elements drives trade growth is a day admire the franchise that has grown 35% since we acquired the business two years ago.
These girls was enabled by the previously mentioned only month. In addition to robust commercial approach that has led to volume he man in previously untapped markets.
We believe that our business is well positioned to come season can be delivered strong growth.
Turning to slide three.
And then she reported more than $1 billion Inc. third quarter revenue, which reflects two year over year increased 10% on a reported basis and 12% organic growth excluding FX headwinds.
This increase was mostly driven by double digit organic growth in Brazil.
Since you know, Mexico friends, India, China and <unk>.
Well those price increases across all regions.
Hi, just the company be though was two on doing a 19 million no. It was an increase or 18% compared to recast financial from last year and $19 million above the midpoint, although the guidance.
Company be demo genes with 21.6%.
One of the <unk> 40 basis points year over year, despite $42 million in combined headwinds from raw material cost and Terry.
I just studied P.S., what 94 cents into quarter.
An increase of 32% versus Threeq, what are we cast Q3, 2018, and 14 cents above the midpoint over again.
The strong outperformance versus the games was driven primarily by higher volume and pricing, which led to a 12.5 cents meat on the babies.
[laughter].
Moving now to stay with quite a revised revenue on slide four.
We really you grow my 10% versus prior year, we will you contributing 8% growth and pricing another 4% growth.
This was oh.
Actually my two girls that headwind from FX.
This was the third country <unk> coffee <unk> tea quarter, then we posted year over year price increase in every region of the world.
Growth in Q3 was stronger than expected due to unforecasted email opportunities.
We saw no shift Oh demand from Q4 <unk> growth in the third quarter was due entirely to Threed NAND.
As expected Latin American made a 45% of its quarterly.
Sales in Latin America grew 21% year over year or 22% organ equally continuing the trend from the first twentys changing.
We posted very strong growth across the region, driven by higher volumes and price increases.
Oh pricing actions more than offset the inside the Olympics.
The minimum was high for applications on cotton and should get came in Brazil.
It is important to note that we continue to monitor channel inventory levels in Brazil, We show well control and inline with expectations for these points in the season.
A market.
Actually it continues to improve in Argentina, which allows us to take advantage of increasing demand for products, especially for next appeal insect cultural and all three to your besides.
Growth in Mexico came from more normal weather conditions compared to all your India.
Year to date have a sales in Latin America grew 29% organ equally.
In the <unk> herbicide and insecticide you man draw your who your revenue growth of 4%.
Despite another very hot summer and fall.
Demand for a new but all the also herbicide benefited from a stronger than predicted see real market.
Yes, Europe led by France, and Germany.
Sales that brings the cultural continued to benefit from new countries registrations.
Price increases.
More than offset.
<unk> process it takes headwind.
Guinea growth was 8% into corridor and stands at 10% year to date.
In Asia revenue increased 5% overall, and 9% organically year over year.
Full English strong Q2.
And yet again <unk> commercial performance driven by demand for insect decides to combat full army warm as well as share gains in the rice, Glenn you will market with their next MP either based Sotera insecticide.
So yes. It brings a cultural was also strong on fruits and vegetables.
We continue to benefit in India from a new commercial organization structure, we put in place about a year ago.
We also see Michigan revenue grew up in Bakkies them, even by strength in the M.I.D. men and new product introductions.
You have today have a sales in Asia grew 7% organically excluding significant if they said when across many currencies.
In North America revenue was down 3% year over year in a seasonally smallest quarter.
As expected we saw reuse demand for herbicide in the Midwest in Canada, that's the weather issues, the spring, resulting in higher channel inventories over those products.
This was partially offset by continued price increases and by shooting for a day and night for specialty crop applications.
Despite the extreme weather related challenges in this region, how do you or do they sales in North America <unk>, one because it.
Turning to slide five.
Third quarter, EBITDA was $219 million, so year over year increased 18% compared to recast results from Q3 2018.
Price increases in all regions and volume he man in Latin America, Asia anyway, what I'm, saying <unk> Oh, he's very strong performance.
Looking ahead of the full year earnings outlook.
We are raising full year on gallons for 29 team.
Revenue is now expected to be into range, well 4.58 billion that rose to 4.62 billion that Chris.
Total company adjusted EBIDA is no there's no expected.
In the range of $1.2 billion to $1.2 billion.
We are also raising guidance for 2018 19 adjusted earnings.
Two Rancho fly with eight to 5.9 dollars per diluted share.
Yes, it's teammates, including the impact of 300 million bettering share repurchases completed year to date through September Thirtyth.
Well as an additional 100 million that are sharing touch is expected in Q4 29 too.
Fourth quarter revenue is now expected to me in the range of $1.17 billion to $1.21 billion, representing 8% growth at the midpoint compared to two weekends fourth quarter 20 aging.
Total fourth quarter company adjusted EBIDA, you know forecasted to be in the range.
302, three and $20 million, representing a 17% increase at the midpoint Russias recast beautiful.
We expect adjusted earnings per diluted share to be in the range of 1.4 seeks to 1.5 station.
That are in the fourth quarter, representing an increase of 3% at the midpoint versus weakest 20, ATM and assuming you into shares outstanding let book, she mentally one or the 3.5 million.
Yeah, all the U.S. group will be constrained by the very low tax rate in Q4 2018.
Looking at the global market.
The crop protection products, we continue to expect 2019 will be flat on a U.S. dollar basis compared to 2018.
We expect the Latin American markets to grew in the high single digit.
In the North American market to be down in the mid single digits.
We expect both <unk> and Asia market.
To be flat to down low single digits.
Oh forecast for the Asian market.
Slightly reduced due due to the strengthening of the U.S. better over the past few more.
These markets forecast than the cheers.
Our expectation that FMC will continue to delever financial outperformance relative to the markets.
Turning now to a full year EBITDA breach and revenue drivers on state Susan.
The main driver of the improve forecast is volume gains, which no contribute 17% year over year, if he that growth.
Pricing actions around the globe are expected to upset about too soon on the combined cost and mistakes in wins.
Sure, but from China has improved we'll do you, but some challenges remain.
The last well the strategy tool or is then what inspected by the recent shutdowns in China, you said two we stuff its production in two weeks.
I would also like to highlight the full year revenue drivers.
We now expect revenue growth of 7% overall and 11% organically.
Both volume and pricing gains have been cold season, its little do you as a reminder, this full year growth well in 29 gene follows organic growth of approximately 13% in 2018 on a pro forma basis.
Moving to slide eight.
We have provided the two drivers for EBITDA and revenue growth in Q4.
Hi, Steve earlier.
We saw no she [laughter] in demand from Q4 into Q3.
In fact, we raised our Q4 revenue guidance.
15 million there wasn't any points.
However, we reduced our EBIDA again for the quarter by $10 million at the midpoint.
Due to higher cost and less favorable FX benefit as compared to a July guidance.
The positive combined impact.
Q4, EBITDA from volume and price mix is exactly the same as we showed you know player but again.
Fourth quarter performance will be driven by strong volume growth in all regions.
Included in these volume on new product launches, we expect to Delever about 20 million that or is over total revenue growth of $19 million into quarter.
These launches.
Include lose Santo fungicide, if those insecticide biofungicide in North America, and say as a pure insect control in South Africa.
In Malaysia and Vietnam.
Pricing actions are expected to fully offset yes, thanks headwinds as a revenue level.
We would also like to highlight the rapid growth side. It was that the insect control which has become.
Fastest growing molecule and he's no fourth largest by revenue.
Forecast the 29 in sales of sales appear insect control are expected to be around 300 million, there's even beverage situation in new countries and clubs.
I will now turn the call over to Mark to take an in depth Luke that are letting them very cabin business.
Thank you Pierre.
Turning to slide nine it has been some time since we reviewed our regions in debt, we thought it would be appropriate to start with Latin America. Since that is one of our key markets in the second half of the year.
It is our largest region by annual revenue and as margins inline with the rest of the world.
Over the next few minutes I will walk you through the business highlights our country exposure as well as crop diversity. In addition, our review I'll go to market strategies and market share as well as discussed growth drivers for the coming years.
First of all I will explain some of the key factors that are driving much higher margins than we had five years ago in this region.
In the Latin America, not subregion, our annual revenue is approximately $130 million to $140 million with Mexico, delivering the vast majority of that revenue.
In a market that is only growing 1% over the past few years, we've increased our market share to approximately 9% as we've grown our business by double digits over the same period.
I'll route to market is generate through local distribution and retail companies.
We have a strong presence in the call market.
We are market leader in central specialty crop markets, where our innovative products help protect fruits and vegetables that will be exported to the U.S. and Europe .
We sell the full range of crop protection products in Mexico, but we have a leading market position and insecticides.
Our portfolio is also complemented by a growing plan health business, particularly biologicals, which represents approximately 5% of our business in the country.
Our Mexican organization also supports our team in Central America, where we work with distributors in all countries for sales into specialty crops such as bananas.
Moving south we come to the Andean sub region comprised of Ecuador, Colombia and Peru.
This sub region is our smallest and lease penetrated in Latin America with revenues of only $15 million to $20 million.
We have less than a 5% share of this market, which is mainly focused on a variety of specialty crops, including bananas flowers rice another kratos.
Our growth is coming from new distributor relationships, which are improving I will grow reach an exposure.
Turning to the South comes up region, where we have revenue of approximately $200 million.
From Argentina, Chile, Uruguay, Bolivia and Uruguay.
We have a market share of approximately 6%.
Argentina is the most significant contributor of revenue in the sub region and in 29 2019 is expected to be Fmcs fourth largest country globally.
Our Argentinian business is focused on row crops with a major emphasis on soybeans.
You account for about 70% revenue in the country.
Over the last three years, we've undertaken a major transformation of the business moving from an exclusive distribution partnership to now a wholly owned subsidiary that sells to multiple distribution and retail companies.
Today, our sales and technical Representatives are present in all the major production areas of the country.
Our authority brand pre emergent herbicides, a market, leading and continue to show strong growth as glycosylated resistance bills across the country.
We also sell a broad range of insecticides and fungicides into these markets.
Our products are also used on corn, sunflower wheat, and specialty crops, such as the growing buying segment.
Chile is an important country for fruit and vegetable crops.
Similar to the U.S. the key to access the Chilean market is to partner with a few large national distributors model, we have successfully transitioned to over the past few years.
Finally, Brazil, our largest country from a revenue perspective.
Represents about 20% to 22% of out total company sales I mean is an extremely important to our long term growth plans.
We had about 9% market share, which was approximately $10 billion in 28 team.
We've had a direct commercial presence in Brazil for decades, covering all the major regions. Today, we have approximately 700 employees in the country of which 300 our agronomists.
These agronomists focus on demand generation, both directly with growers and by partnering with retailers to help grow as find solutions for that problems.
We have leading positions in the sugar cane cotton markets, and sub growers and sugar mills, either directly or through alliances and cooperatives.
We also one of the top three players in citrus rice coffee and tobacco.
As we expand our market access we have seen soybeans and corn become our fastest growing segments.
We have developed multiple routes to access these large yet fragmented markets in Brazil.
This access enables direct sales to the very large growers in the serrato area, mainly Mato grosso by ear.
We also have partnerships with regional retailers throughout the country and long lasting relationships with virtually all the leading cooperatives.
Please call up started in the south setting soybean corn coffee wheat and show the crops.
But are also expanding into the serrato area.
They are very important relationships for our growth.
As we advance our market access initiatives. We've also paved the way for future launches of new products out of our pipeline, especially for row crops.
And finally, we are also leading player in the biological segment, particularly Biomets asides.
Quote so by and I might decide as quickly taken substantial market share in sugarcane and most recently in coffee since it was launched for the 2018 growing season.
Presence biomass aside was launched at the same time and is growing very fast as a seed treatment on soybean and corn.
Combined caught some presence buying them anthracites cover a broad range of crops and provide nematode control both in federal applications in permanent crops and seed treatment in annual row crops.
Completely replacing older synthetic chemistries.
We had a growing pipeline of new biological products that will allow further growth opportunities.
Turning to slide 10, you can see in the table in the upper left at FMC is Latin American business is expected to grow revenue by about $400 million.
From $1 billion in 2017 to approximately $1.4 billion in 29 team.
The map on this page highlights the breadth of coverage we have across the region.
In addition to FMC being a much larger company in Latin America than we were a few years ago. We believe we are a market leader in the way, we proactively address structural market challenges, particularly in Brazil since 2015.
Our disciplined to business practices are driving our outperformance and position FMC to continue to thrive in the region.
As you May recall, we took full brought actions in the 2015 to 16 to better position our business in Brazil and to raise profitability.
First we reduced our cost base of restricted our business to better match market conditions at the time.
Second we became more disciplined in our sales process, mainly with sales terms and cash collection.
Third we eliminated sales of low value products from our portfolio selling only products, where FMC was able to achieve acceptable financial returns.
And fourth we significantly reduced the amount of FMC product in the distribution channels.
These actions dramatically improved the performance of the business beginning in 2017.
When you layer in the significant benefits that came with the recent acquisition from Paul.
From portfolio enhancements to customer access to R&D capabilities and a deeper pipeline you can understand why we are confident about our potential to continue to grow in this region.
As you know Latin America can be volatile region in terms of markets in currencies.
However, we have put in place several proactive leave us to ensure our business growth is sustainable.
These include diligently tracking channel inventory on a monthly basis in Brazil to keep it at a low level.
Implementing OLED hedging program to mitigate FX risk in Brazil.
Borrowing in local currency, where practical to reduce currency exposures.
Robust pricing process to quickly react to local currency volatility.
Building a team of credit specialists to assess credit worthiness of potential customers and to limit sales when necessary.
And finally, utilizing more collateral and barter arrangement to mitigate collection risk.
All these factors helped to create a Latin American business with earnings margins that are comparable to our margins in other regions.
Now turn the call over to Andrew.
Thanks Mark.
Let me start this morning with a few specific income statement items.
Interest expense for the quarter was $5.5 million higher than implied by our prior full year guidance, primarily due to higher than anticipated foreign borrowings additional interest, resulting from the refinancing completed in September as well as slightly higher than anticipated commercial paper balances in rates.
Interest expense for the full year is now expected to be in the range of $153 million to $157 million.
We revised our expected adjusted effective tax rate for the full year to 14% to 15%.
Reflecting our updated expectations for earnings by jurisdiction.
With this change in full your expectations, the resulting adjusted effective tax rate for the third quarter was 12.6%.
Weighted average diluted shares outstanding for the third quarter was 131.6 million down nearly 5 million shares versus the prior year period, reflecting the benefit of the $500 million in share repurchases, we've made over the past four quarters.
EPS growth was particularly robust in the third quarter lower share count taxes, and minority interest more than offset higher interest expense to expand EPS growth of 32% versus the 18% growth in EBITDA.
As to your outlined earlier, we're expecting very strong financial performance in the fourth quarter with revenue growing 8%, an EBITDA growing 13% at the midpoint of our guidance ranges.
Expected EPS growth of 3% is muted by a very low tax rate in the prior year period, which resulted from a year end true up of the full year tax rate last year.
Moving onto the balance sheet and debt.
In September FMC raised $1.5 billion of new debt equally weighted across seven tenant 30 year maturities. We use the majority of the proceeds to immediately reduce both Tom on that and commercial paper balances.
We will use the remaining proceeds to redeem $300 million in senior notes maturing in the fourth quarter.
As all proceeds are being used to pay off other debt this offering will be leveraged neutral.
However, we successfully extended the maturity profile of our debt at attractive rates.
Further the offering was spot 4.5 times oversubscribed, which has the company had not been to the bond markets. At some time was a strong endorsement of FMC strength and the either fixed income investors.
Gross debt as of September Thirtyth was $3.6 billion up roughly $360 million from the end of June .
After adjusting for the $300 million and remaining proceeds from the September debt offering their held aside for the retirement for our of our 2019 senior notes in the fourth quarter gross debt to trailing 12 month EBITDA at quarter end was 2.8 times.
This is above our targeted leverage is 2.5 times due to some shifts in working capital across quarters versus our initial forecast and the timing of share repurchases.
We continue to expect to see leveraged dropped to 2.5 times are lower at year end a level at which we would expect to remain at or below on average through 2020 and beyond.
Turning to slide 11.
Adjusted cash from operations was $301 million for the third quarter.
Despite strong earnings and collections cash from operations with somewhat lower than expected due to payables.
Payables were negatively impacted the quarter by purchases made from alternative suppliers to limit the impact of disruptions from Chinese suppliers.
Payable terms with our Chinese suppliers are generally longer than the temporary terms are these alternative suppliers.
This situation will naturally reverse in the fourth quarter as we rebuilt payables with Chinese suppliers and enter into longer term arrangements with alternative suppliers.
Capital spending accelerated in the quarter as expected, while legacy and transformation of spending was largely inline with expectations.
Resulting in free cash flow before dividends and repurchases of $198 million.
We are maintaining our full year guidance for free cash flow of $375 million to $475 million.
This implies very strong cash from operations in the fourth quarter, given our cash generation year to date, and our expectations for capital spending and legacy and transformation costs.
Cash from operations will be driven by robust profitability and working capital release, including the expected improvement in payables.
We continue to explore a smaller product line acquisition and may accelerate the start of certain capital investments to support the rapid growth of our time platform.
These opportunities it pursued reduced full year free cash flow somewhat so they would further reinforce our growth trajectory.
We have repurchased 3.7 million FMC shares year to date at an average price at $80. A 95 cents for a total of approximately $300 million, including 1.1 million shares purchased in the third quarter.
We intend to be a regular purchaser at FMC shares.
Although we have not purchased any shares since quarter end, we intend to purchase an additional $100 million of equity shares during Q4, bringing the full year total to $400 million.
Our full year EPS guidance reflects the benefit of anticipated repurchases in the fourth quarter. So this benefit is modest given the limited remaining time in the year.
Before turning the call back up here, let me also give a quick update on progress and implementing our new S&P S. Four high ERP system.
After a successful go live in Brazil in July the third quarter was the first quarter in which we closed with roughly 20% of the company on the new system.
The close was uneventful and our Brazil team is excited about the many new tools and capabilities of asked for hot.
We expect to exit the TSA in February when we will go live with us for hot across the acquired business.
The remainder of the company will migrate to as forehand out later in the year 2020.
The new system more thoroughly modernize our business process environment, delivering meaningful near term benefits and providing as a platform for driving further improvement in the future.
And with that I'll turn the call back over to Pierre.
Thank you Andrew.
In December 2018, we shipped a five year plan with annual sales growth of 5% to 7%.
The growth of 7% to 9%.
Yes growth above 10% failure.
Based on the against for Q4, we expect to Delever. The high end of the range in the first year and expect to meet our objectives in the remaining four years of the plan.
We continue our focus on driving strong growth through technology.
In 2019, we expect about $60 million over total revenue growth of $315 million will come from new product.
Yes, Kevin Marine and new product pipeline are advancing as expected.
Two new molecules move from discovery to development in 2019, including in safety study in January and then there will be side in October .
These are significant steps in advancing products toward commercial launch.
We are pleased with the performance of the company.
We delivered another strong quarter and are expecting this strong year.
Our technology advantage portfolio geographical balance crop exposure and diversified products trashing continued to drive our financial performance.
I will now turn the call back to the operator for questions. Thank you very much for your attention.
Ladies and gentlemen, if you would like to asking a question at this time. Please press Star then the number one on your telephone keypad. Please limit yourself to one question only if you have additional questions. You can jump back in Q2 is drawn yourself from here anytime press the pound key and again, please limit yourself to one could.
Machine only and we'll pause for just a moment to compile acuity roster.
And your first question comes on line of on PJ Juvekar with Citi. Please go ahead.
Yes, good morning.
Mark very helpful or view on Latin America.
Looking at your Latin American market share, it's all less than 10%.
So that seems like a big opportunity in the future.
This is market shares compared to other mature markets and what's what how would you.
Got it could rise opportunity there.
Yeah, Hey, Jay I think I think you're right. When we look at Latin America, we do see continued opportunity to grow and take market share I think obviously was strongly in Brazil in certain segments as I highlighted but frankly as we introduce our pipeline across the region, we see growth opportunities outside of Brazil that will.
Raise our market share in particular places like Argentina, where frankly.
We didnt have great market access, but now we have and we're seeing that accelerated growth.
Not only on the on the Big Soi business as I talked about but on some of the most specialty crops as well.
I think those margins sorry those.
Those market shares in some of the other regions outside of Brazil.
Lower than some of our more established markets to be expected given our market access. So yes, I mean, I said it in the script that Latin America will be a major driver of our growth going over the this five year plan and beyond we see no reason that won't continue to accelerate given where we think help portfolio face and morning.
Certainly the market access that we continue to build across the region.
Thank you.
Your next question comes from Chris Parkinson with Credit Suisse. Please go ahead.
Thank you you highlight a few implied for Q cash flow drivers on slide 11 of your presentation and flags is strong collections, presumably in Latam as well some inventory discipline. Just can you highlight on what degree of confidence or general line of sight do you already have into these improvements and how we as investors should be.
Give out these better conversion into next year as wells into 2021, just to keep puts and takes thank you.
Thanks. This is Andrew Glenn just give you some some quick comments on on the cash flow for Q4, certainly collections are expected to be robust in Q4 actually be driven more out of Europe and Asia terms of the seasonal build a receivable so I see a builder receivables in Latam in Q4 with that the entry into the new season.
Yes in terms of line of sight, there, we feel very confident in the collection forecasts.
For Europe , and Asia, North America, There's some collection this last prepays and rebates as to the puts and takes in the quarter there.
I think when we look at inventories we've been very very focused on managing our inventory this year.
It it is simply a place where we have opportunity as we get better systems as a better visibility with our new Asap system to drive further efficiencies, but we feel confident in our inventory forecast for the full year.
I think the payable situation and we mentioned in his prepared comments just some short term impacts from having to use alternative suppliers with shorter payment terms during the middle of the year, yes that will reverse as we go into into the end of year. We can see that as were building payables with our more traditional suppliers and then longer terms. So all in.
Well I think yes. It is a large release of working capital in Q4, but we think we have very good visibility there.
Okay. Thank you.
Your next questions from the line of Mark Connelly with Stephens. Please go ahead.
Thanks.
I think the biggest question that we're getting from investors now is on the legacy and transformation costs, which are such a huge drag on on free cash can you help us understand how those begin to roll off across two 2020 and 2021.
Sure Hey, it's Andrew again Mark.
I certainly understand the questions then I think at the key part of our long term cash conversion improvements stories is managing these legacy and transformation costs. After this year, we've guided legacy and transformation costs of 200 at $250 million.
That about 100 of it is true legacy costs, which are some of these environmental and other liabilities that are part of our long heritage as a previously very diversified conglomerate. There's a very those are pretty stable pretty predictable, but they're not going away.
Next hundred 50, which is really the transformation is spending a combination of finishing the integration that upon acquisition and the work we're doing around the company to implement the safety EPS more honest system Thats. The additional 100 150 that you see this year that spending should step down materially in 2020, but will not go away.
And then in 2021, I would expect that spending to go to a very low level as we moved to a different phase.
More steady state operation. So when you think about our cash conversion and the way we've spoken about it as a as a percentage of our adjusted earnings net income.
$150 million transformation spending relative to roughly 770 and net income were forecasting for this year that alone would be a 15% increase in cash conversion for the company.
So you'll see some benefit in 2020, but the most substantial benefit you'll see in 2021.
Also continue working on working capital improvement.
And just the growth of the of the underlying operating cash flow to drive up that cash generation.
Very helpful. Thank you.
Your next question from Adam Samuelson Goldman Sachs. Please go ahead.
Yes. Thank you good morning.
I was hoping you could provide a little bit of color just on cost trends as we go into Fourq, you and kind of what that implies into 2020 how.
Raw material costs have been tracking that some of the impacts of the supply disruptions in China and potentially moving past that kind of where cost inflation is just aggregate level is for fourq Hewitt into the first half of the year.
Yes, certainly I think.
So Jim will comment I would make around cost is.
He does being continuing into the signal for the year, maybe beyond what we were expecting at the beginning of the year.
As you see on the owner against four EBITA I will address costing the fourth quarter of of $40 million. We above the same number for the Q3 TV that 39 million. There are so all you know the too.
Together close to $80 million, where we had about 100 million letters in the in the first half. So we had a continuation of the caused mostly due to the China disruption.
And some of the the told us new shutdown.
As a as we say prepared remarks, we expect those as the strategic solar.
To be back on stream in a couple of weeks. So most of the major partners and suppliers, who will be will be back on track. So Lisa if I think those comments now and extrapolate too to 2020 and maybe I'll use that you could you kind of goes on 2020 .
You will 2020, we believe we'll do you directionally the global level, a beat equivalent to two 2020 19, but with some differences.
In 2019, we had Latin America growing.
Very fast in the high single digit so difficult to expect another year end use they've also we could see Latin America slightly lowering growth ending 2019 on the other hand.
We could see North America, seeing better condition, and we had a negative mid single digit for 19. So we could expect 2020 to be stronger so owning or maybe slightly slower in a in Latin America faster in North America balancing out and Directionally same thing floor for Europe and Asia.
If you look at what we talked about costs caused in 2020 will be the tailwind.
They will be favorable versus 19 that being said they will not be favorable to the extent we were thinking at the beginning of the year because we saw a continuation of those cost into the into the second half of the.
2019, and that will impact.
The cost of product into into 20 into 2020 interface between only for us to US we'll look at.
It's going to go next year.
If I put all that together.
You will affect your plan.
Revenue growth into 5% to 7% EBITDA growth in the 7% to 9% and and the EPS growth over 10% seems to be quite to quite achievable and for the 2020 year.
I really appreciate all that color. Thank you.
Thank you.
Our next question from Vincent Andrews with Morgan Stanley . Please go ahead.
Thank you.
The comments on the Asian market.
Celebrating versus expectation due to due to foreign exchange is that a function of actual decline and take away at the end user a grower level or is that just sort of management of working capital by the intermediaries in the supply chain.
Yeah, Vincent as mark bit of both actually.
Asia is such a big part of the wells that you have different conditions around roundish I'll give you a quick run around those out as I see it today, Australia very very difficult market extremely dry.
Not in good shape at all.
Indonesia in much better position, some will elevate your channel inventories, but not everywhere.
Monsoons are pretty good in India.
We had.
We have very good business in India channel inventories at normal levels China.
Difficult market in China lots going on lot of movement going on in terms of companies repositioning themselves channel inventories, okay. Some areas slightly high.
Rest of Southeast Asia very good.
Pakistan very good for us very good season, so I think that decline generally as part of what the asset is the currency impacts that we've seen over the last few months, but part is some of the some of the actions in some countries to make sure that everybody is on top of that business.
Thanks very much.
Your next question from line of Laurent far with Exane. Please go ahead.
Hi, good morning.
Let me turn question for me. Please on insecticides, we're hearing a bit more on phase out three is concerned.
Phosphates and I'm just wondering if you guys do you see theres an opportunity.
To grow share in dynamic so do you think that's.
Those phase out some more likely to switch over to cheat on tenant is done Dan. Thank you.
Yes Laurel.
Some of the product you're talking about the diameters actually, particularly cyazypyr would have a fit in that market, but it is a more of a low value market than where the dialogue. That's traditionally would fit so yes, the could be an upside, but whether we would want to take it and I don't know at this point, we do have other chemistries, though in our portfolio.
Very strong such as the pirates rights, which fit very well. So we do see those are all going to phosphates that are going away.
The marketed in commercial teams do see it as a potential upside for us in the coming years.
Thank you.
Your next question from Frank Mitsch with from Research. Please go ahead.
Hey, good morning, and congrats on a nice quarter.
Intrigued by the comment that the exit the market access to Argentina has been improved.
Can you talk about how specifically and what are the implication for 2020 growth and beyond.
Yeah, Yeah. Thanks, Frank I'll, let mark at any addition, but it's quite a simple situation from a market access for us we.
We use a couple of years ago, we used to heat through a an exclusive arrangements. We the distribution company in which we had an equity participation. So we will not truly running.
Market access and we are very dependent upon a a distributor we oh, we broke that relationship and the end do have an organization today, we see direct relation with the the the market in Argentina. So we can just structure to a structure, which is much more similar to what we.
In other parts of Latin America, unreserved or other other countries in the oil which is a direct FMC market access with a larger and may be more traditional organization Mark if you will not anything when these yes. In addition to won't be as said Frank.
We we had that traditional relationship that we bought cheminova, which give us some market access as well and then the Dupont assets came along and we had better market access. So we had a very complex situation, where we essentially have three organizations that we had to bring together we've got through all of that now and in fact, PR and I were down in Argentina or about three weeks ago I have to say.
The growth we're seeing today, frankly, I think it will continue to accelerate.
As we go over the next three to five year period. The team is really on covering a lot of growth opportunities on the portfolio fits very well in Argentina. So it's a highlight for us it's a country that we're focused on we're investing in more resources. So expect to hear more about it from US I think when when you think about a question former from BG at the beginning around market share.
Clearly Argentina for us when you when you look at the blend of changing market access together with portfolio that is going to be a place where we do have a great opportunities in the future.
Terrific. Thank you.
Thank you.
Next question from Joel Jackson with BMO capital markets. Please go ahead.
Good morning.
Maybe give a little more color on some of the where you've got progress right now on possibly expanding die meat production over the next one awhile and also do you have any progress on coffee locking in some customers competitors on some longer term agreements to produce for not experience aspect for them. Thanks.
So Joe just you cut out a little bit did you said the dynamite capacity, we did the beginning of your crude.
Yeah, just sorry, so tiny production you talked about possibly expanding more you have to get a little bit occur on this call maybe give a little bit more and so what will decide the timing of that longer term have you guys any progress on locking in some arrangements.
Or some terms that you may lock into for producing an x. correct, that's pair for customers and competitors. Thanks.
Yes diamonds, what we spent the last two years basically de bottlenecking what we.
What we acquired and I have to say the supply chain group of manufacturing done an excellent job and feeding us more diamonds, and allowing us to continue that growth trajectory over the last couple of years. We are looking now at what excess capacity that we need to build for our next phase of growth. So that is not something thats hitting right now.
But it is certainly something as we alluded to on the capital front that we're looking at.
The I think the other the other aspect to this is what you were alluding to where we talked last time about the relationships that were building. We are progressing those relationships and I, obviously cant I can't speak to them in detail given the confidentiality nature, but suffice to say that they moving forward and we're very pleased with where we are with the breadth of.
Those dynamite potential relationships and actual relationships one thing I would like to add.
Around the growth of the dialogue sites. Some of you will remember back in 2018, I talked about part of the aspect of the growth that we were seeing was the fact that we had about 200 registrations and label expansions that we were looking at that would allow us to increase our market space and allow the growth to continue.
Well, we are today out about 200 about a 100 of those registrations and label expansions are now in place. So hence you see when we talk about places like Vietnam lightly lazier like say as appear in the Philippines. We now have registrations that we didn't have before so that naturally opens up new.
As far as and accelerate the growth.
Something that we've put in place over the last 18 months is not only the fact that we originally had 201 hundred to those are now real we now have another 240 registration and label expansions on top of what we had at the beginning of 28 day. So if you think about it in terms of how.
We see our market expansion different crops different pass different geographies that growth will continue to go for the next 510 plus years easily given what we see from a registration on label expansion.
And that comment made by might relate a very well to the commenting that prepared remarks around sales up here being now the floor now just molecule really to assess those green molecule and close with 300 me on that as great growth potential here.
Thank you.
Your next question from Steve Byrne with Bank of America Merrill Lynch. Please go ahead.
Yes, the two big seed companies have recently rolled out from bundles and the U.S. market, where theyre, they're bundling their seed physician with farmers to also drive crop chemical sales and I just wondered if you're if you're seeing any evidence of that at the distributor or retail office.
Where there could be a shift over to those those chemistries.
You mentioned.
Lower pre emergent herbicide sales and in the us in the third quarter.
I would assume thats not.
Demand for pounds on the ground product, but channel refilling on whether there's anything going on there with respect to the these dynamics in the market.
Yes, Steve.
Good question.
First of all they're all programs being rolled out, but nobody knows all the details of them yet so it's a bit of a premature but have a premise your questions as to how will it impact there are some high level views of what those programs look like yes, let's be clear.
We have very very strong relationships with major distributors in the us.
Those major distributors continue to show.
Very strong partnerships with us given the growth rates, but we have especially around our new technologies.
We also have very strong programs in place the FMC Freedom pass program in the U.S. has many different aspects to it that allow us to reward both retailers and growers for using our products on various different acres on crops. The advantage that we have we're not tied to anybody seats you can.
Use whoever seed you want and we will provide the best chemistry. So certainly we have seen no impact on those programs. This year and I can tell you given where the commercial group saw next year with regards to growth of new products and especially on the specialty crops. We don't think thats going to have an impact at all in our business in the U.S I.
Just just would like to.
To reinforce what Mark said, Mark and I we.
We spend a large amount of time, we there are customers in the us in the be retailers.
I can tell you.
We have no doubt.
The the.
The retail world in the U.S. welcome a.
Crop chemical.
Company, which is focused on those biologicals and chemicals with no seed and we see that mostly due to the seed and doesn't bundled product.
And we needed to us over and over if anything today I would say, it's one of this strength the thing that we do not FCS and one of the driver of growth.
And any comments on the pre emergent herbicide sales in the third quarter.
No it's pretty much what we expected actually we knew we had channel inventory that it's still too early to say how the next season will go we're not even in discussions yet around.
What will happen in Q4 in Q1 for that business.
Thank you know we have class, leading chemistry with our authority brands and what's more important out of those authority brands. The very high end of those brands the ones that have the highest technology, they're the ones that have the fastest growing so.
Not all pre emergents amid equal and we do participate across the whole spectrum, but have a lot of products at the very high end.
Okay. Thank you.
Your next question from line of around the Swanson with RBC capital markets. Please go ahead.
Hi, Thanks, Good morning, guys congrats on great quarter.
Just wanted to ask about the the price mix and the cost.
So in 19, it looks like you got to my 156 million on price mix.
Thats your expectation for the full year and.
Like the one in five on costs.
Maybe you can just help us and provide a little bit more detail now.
The next year.
Some of the 159 from tier fan S&P would roll off.
Im curious on the on the Rod side, how much of that you would get potentially get back I know you said it will be less but.
How much of that would you get back and price mix, if you're not getting back as much do you expect a little bit better performance enterprise Max Thanks.
Yes. Thank you I you know.
Appreciate the question because it's an important question, but it's a bit too early for us to a two really stayed the rule materially impact next year clearly the adverse impact hi, it's going to be we believe it's going to be a tailwind compared to two the number we had we had the this year.
In some of the 180 million their cost we were facing but but it should be early we ask you digging through the numbers looking at the impact of other major solar restarting in a couple of weeks.
We will have lots of detail in the forecast that the February call, but difficult to a difficult to to assess that number we will adjust.
As we always do pricing strategy to the currency situation tend to enter the cost we are seeing.
But we need another win another few weeks to be able to see if those numbers.
Okay, then just as a quick follow up Latin America now, yes, 31% of your revenue or so this year.
Yes.
Thats kind of ebb and flow and you still expect kind of a 25% makeup across your regions for each and the ensuing years.
Our Latin America continues to be your largest region. Thanks.
Yeah, I think you know, we often talk about that geographic balance I think this year, obviously Latin Americas at an accelerated accelerated year. So it's as you said I think is 30, 31% I would expect over time.
It stays in that in that range. It is one of the largest markets in the world one of the fastest growing it's one of the only place is on Earth, where you have more land that can be turned to agriculture. Many from converting pastureland to agriculture in Brazil. So you, obviously going to have that impact I would say that.
Longer term Asia will also continue to grow rapidly, especially for us given our excellent portfolio on frozen vegetables, and the other crops in India and Southeast Asia, especially so I think you might see a little more balancing what Asia.
North America in Europe , I expect pretty much steady as it goes in those sort of ratios.
Any point any you could have one region green laser and taking a stronger position I think these balances out.
In the over the years.
North America, we don't expect the year next year CBS , but as this year I mean, everything could happen that really was a very negative year in North America injuries variable situation Latin America that could reverse.
Next year at any point. So all you know each was done on said marks Asia, we should know that other his team made the potential we have in a in India.
Yeah, He's a very large country with us the portfolio on the news should commercial structure. We are in place is going to create you, Michigan growth, which in the future. So all of these to say that these 25 cents per region.
Over the year should should remain just kind of the range.
Good.
Your last question comes from the line of Chris Kapsch Loop capital. Please go ahead.
Yeah. Good morning, you did address my question about the dynamics in North American and entered into that's where I was wondering.
Sanguine view about prospects.
I guess, one nuance on that though is.
I understand the strong relationships with the channel partners that you referenced is is it just also just a function of your.
The competitive dynamic based on channel inventories going into 2020 any comments on that.
Yes.
It's pretty much as you said, Chris when you think about it soybeans, obviously important to us, but we're not on every acre of soybean where you have what you have strong weed resistance, you're going to see our authority products.
Certainly as you said in the Holzshu, California, all the way round the south of the East Coast, where you have specialty crops, we have a super portfolio. The fits Darrin continue to grow so you're going to have that that different type of mix from FMC, which is different. So as you said some of the other companies that have a very large row crop exposure that's advantageous to our.
Distribution partners and retail partners, we offer them products that are very different and a different type of mix. So yes, we do consider north America to be very very important market for us with a lot of growth opportunities.
Yeah. Thanks for that and then just one follow up on on Latin America, and Argentina, specifically, you had pretty bullish comments about gaining share overtime. There given better access can you just talk about the obviously this recent election that the result was taking on a couple of months go on the based.
You'd on the preliminary results.
Just any influence that has on.
Your operations your ability to execute a growth plan in that country. Thanks.
Hey, it's Andrew Chris I think good question, I think with Argentina, and the market is it for our products is us dollar denominated. They are some some delays in collections that can create a little bit of FX exposure.
But yes, while there were certainly be challenges with featured likely feature devaluation in Argentina, we think it's quite manageable.
It is at the issues around capital controls et cetera, et cetera are also quite manageable for us in terms of bringing in pretty necessary crop inputs.
That's something we watch very closely but not something wherever like concern about at this point.
Alright, Thats all the time after the call today, Thank you and have a good day.
Ladies and gentlemen, this concludes the FMC Corporation conference call. Thank you.